REUMACO OÜ

Active Registry code 12982379 OÜ Tallinn Registered 22 Jan 2016
Compare

REUMACO OÜ is a OÜ based in Tallinn, registry code 12982379, status: active. Main activity: Other research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q2 2023 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q2 2023 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2021 0 €
    industry median 0 € · companies in the industry: 837

Taxes and turnover

Q1 2022 – Q2 2023
Turnover, € Q2 2023: 0 € · industry median 15 775 € · above 2% of the industry
05 00010 00015 00020 000Q1 2022 Company: 0 € Industry median: 18 427 €Q1·22Q2 2022 Company: 0 € Industry median: 19 195 €Q2·22Q3 2022 Company: 0 € Industry median: 15 454 €Q3·22Q4 2022 Company: 0 € Industry median: 16 080 €Q4·22Q1 2023 Company: 0 € Industry median: 17 387 €Q1·23Q2 2023 Company: 0 € Industry median: 15 775 €Q2·2305 00010 00015 00020 000Q1 2022 Company: 0 € Industry median: 18 427 €Q2 2022 Company: 0 € Industry median: 19 195 €Q2·22Q3 2022 Company: 0 € Industry median: 15 454 €Q4 2022 Company: 0 € Industry median: 16 080 €Q4·22Q1 2023 Company: 0 € Industry median: 17 387 €Q2 2023 Company: 0 € Industry median: 15 775 €Q2·23
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q2 2023 — — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2016 – 2025
Revenue, € 2021: 0 € · industry median 0 € · above 5% of the industry
0501001502002502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 242 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €20202021 Company: 0 € Industry median: 0 €20212022 Company: — Industry median: 103 €20222023 Company: — Industry median: 76 €20232024 Company: — Industry median: 0 €20242025 Company: — Industry median: 0 €20250501001502002502018 Company: — Industry median: —2019 Company: 242 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €2021 Company: 0 € Industry median: 0 €20212022 Company: — Industry median: 103 €2023 Company: — Industry median: 76 €20232024 Company: — Industry median: 0 €2025 Company: — Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -85 € · +0.0% vs 2024 · industry median 0 € · above 32% of the industry
-12 500-10 000-7 500-5 000-2 50002 5002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -11 236 € Industry median: 3 €20192020 Company: -400 € Industry median: 28 €20202021 Company: -350 € Industry median: 1 €20212022 Company: -370 € Industry median: 0 €20222023 Company: -384 € Industry median: 0 €20232024 Company: -85 € Industry median: 0 €20242025 Company: -85 € Industry median: 0 €2025-12 500-10 000-7 500-5 000-2 50002 5002018 Company: — Industry median: —2019 Company: -11 236 € Industry median: 3 €20192020 Company: -400 € Industry median: 28 €2021 Company: -350 € Industry median: 1 €20212022 Company: -370 € Industry median: 0 €2023 Company: -384 € Industry median: 0 €20232024 Company: -85 € Industry median: 0 €2025 Company: -85 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 1 271 € · −6.3% vs 2024
01 0002 0003 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 2 945 €20192020 Company: 2 545 €20202021 Company: 2 195 €20212022 Company: 1 825 €20222023 Company: 1 441 €20232024 Company: 1 356 €20242025 Company: 1 271 €202501 0002 0003 0002018 Company: —2019 Company: 2 945 €20192020 Company: 2 545 €2021 Company: 2 195 €20212022 Company: 1 825 €2023 Company: 1 441 €20232024 Company: 1 356 €2025 Company: 1 271 €2025
Equity, € 2025: 1 271 € · −6.3% vs 2024
01 0002 0003 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 2 945 €20192020 Company: 2 545 €20202021 Company: 2 195 €20212022 Company: 1 825 €20222023 Company: 1 441 €20232024 Company: 1 356 €20242025 Company: 1 271 €202501 0002 0003 0002018 Company: —2019 Company: 2 945 €20192020 Company: 2 545 €2021 Company: 2 195 €20212022 Company: 1 825 €2023 Company: 1 441 €20232024 Company: 1 356 €2025 Company: 1 271 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — -85 0 1 271 1 271 0
2024 — -85 0 1 356 1 356 0
2023 — -384 0 1 441 1 441 0
2022 — -370 0 1 825 1 825 0
2021 0 -350 0 2 195 2 195 0
2020 0 -400 0 2 545 2 545 0
2019 242 -11 236 0 2 945 2 945 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-6.7 %
Net profit / equity
Return on assets (ROA)
-6.7 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 9 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 15 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 17 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 1 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 29 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 27 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 2 Jun 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72191Other research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
Ä 50022765 / 4
3 Sep 2023
Amendment entry In force
3 Sep 2023
PDF
Ä 50022765 / 3
20 Jan 2018
Amendment entry In force
20 Jan 2018
PDF
Ä 50022765 / 2
11 Dec 2017
Amendment entry In force
11 Dec 2017
PDF
Ä 50022765
22 Jan 2016
First entry In force
22 Jan 2016
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data